title: Role played by paxillin and paxillin tyrosine phosphorylation in hepatocyte growth factor/sphingosine-1-phosphate-mediated reactive oxygen species generation, lamellipodia formation, and endothelial barrier function.
abstract: Paxillin is a multifunctional and multidomain focal adhesion adaptor protein. It serves as an important scaffolding protein at focal adhesions by recruiting and binding to structural and signaling molecules. Paxillin tyrosine phosphorylation at Y31 and Y118 is important for paxillin redistribution to focal adhesions and angiogenesis. Hepatocyte growth factor (HGF) and sphingosine-1-phosphate (S1P) are potent stimulators of lamellipodia formation, a prerequisite for endothelial cell migration. The role played by paxillin and its tyrosine phosphorylated forms in HGF- or S1P-induced lamellipodia formation and barrier function is unclear. HGF or S1P stimulated lamellipodia formation, tyrosine phosphorylation of paxillin at Y31 and Y118, and c-Abl in human lung microvascular endothelial cells (HLMVECs). Knockdown of paxillin with small interfering RNA (siRNA) or transfection with paxillin mutants (Y31F or Y118F) mitigated HGF- or S1P-induced lamellipodia formation, translocation of p47 (phox) to lamellipodia, and reactive oxygen species (ROS) generation in HLMVECs. Furthermore, exposure of HLMVECs to HGF or S1P stimulated c-Abl-mediated tyrosine phosphorylation of paxillin at Y31 and Y118 in a time-dependent fashion, and down-regulation of c-Abl with siRNA attenuated HGF- or S1P-mediated lamellipodia formation, translocation of p47 (phox) to lamellipodia, and endothelial barrier enhancement. In vivo, knockdown of paxillin with siRNA in mouse lungs attenuated ventilator-induced lung injury. Together, these results suggest that c-Abl-mediated tyrosine phosphorylation of paxillin at Y31 and Y118 regulates HGF- or S1P-mediated lamellipodia formation, ROS generation in lamellipodia, and endothelial permeability.
authors.affiliation: Department of Pharmacology, University of Illinois, Chicago, Illinois, USA.
authors.forename: Panfeng
authors.initials: P
authors.lastname: Fu
authors.affiliation: Department of Pharmacology, University of Illinois, Chicago, Illinois, USA.
authors.forename: Peter V
authors.initials: PV
authors.lastname: Usatyuk
authors.affiliation: Department of Medicine, University of Illinois, Chicago, Illinois, USA.
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Jacobson
authors.affiliation: College of Medicine, University of Arizona, Tucson, Arizona, USA.
authors.forename: Anne E
authors.initials: AE
authors.lastname: Cress
authors.affiliation: College of Medicine, University of Arizona, Tucson, Arizona, USA.
authors.forename: Joe G N
authors.initials: JG
authors.lastname: Garcia
authors.affiliation: Department of Medicine, University of Chicago, Chicago, Illinois, USA.
authors.forename: Ravi
authors.initials: R
authors.lastname: Salgia
authors.affiliation: Department of Pharmacology, University of Illinois, Chicago, Illinois, USA ; Department of Medicine, University of Illinois, Chicago, Illinois, USA.
authors.forename: Viswanathan
authors.initials: V
authors.lastname: Natarajan
keywords: c-Abl; endothelial barrier; lamellipodia; paxillin; reactive oxygen species; tyrosine phosphorylation of paxillin